FNDC5 and sarcopenia: However, another cross-sectional study found that serum irisin levels presented no relationship with sarcopenia status and relevant clinical muscle parameters, which did not support the conclusion that Irisin can be used as a biomarker of sarcopenia in the population-based study [36].